 |
| |
| TRT is applying technical and working knowledge of our rich source of stem cells and
synthetic scaffold material to advance clinical treatments within the medical
community. These technologies are commercialized through established corporations
and technology licensing agreements. |
| |
| Read More... |
| |
 |
| |
 |
| |
| The HUCPVC stem cells represent a platform technology. These cells are equivalent to bone marrow mesenchymal stromal cells. |
| |
| Read More... |
|
 |
 |
|
 |
| |
| By working with clinicians, TRT continues to develop innovative methods to use stem cells as drugs for the benefit of patients. |
| |
| Read More... |
|
|
| |
| |
|
|
 |
| Development of HUCPVC
Therapy™. Non-embryonic stem cells for patient care. |
 |
 |
| HUCPVC Storage™ for the long-term
storage of Umbilical Cord Tissue stem cells collected at the birth of your baby. |
|
 |
| Assisting the natural renewal and
remodeling of bone with OsteoScaf™, our
macroporous biodegradable scaffold. |
| |
|
 |
|
|
| "It's a new type of Biological Life Insurance!" |
 |
|
|
|
|
|
|
| |
|
